Navigation Links
Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer
Date:12/17/2009

WALTHAM, Mass., Dec. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cost of Roche/Chugai's Avastin, followed by concerns about its efficacy and side-effect profile, are cited most frequently by surveyed oncologists as the factors preventing their use of Avastin for non-small-cell lung cancer treatment in Germany, France, Italy, Spain and the United Kingdom.

The new Special European Physician & Payer Forum report entitled Targeted Therapies for NSCLC: How High are the Barriers to Displacing Avastin in Europe? finds that Avastin, which is not recommended for use within the United Kingdom's National Health Service, is used more often for non-small-cell lung cancer in the first and second line in France and Germany than in Italy and Spain. However, over the next 12 months, surveyed oncologists in Italy and Spain expect to increase first-line use of targeted agents such as Avastin, OSI Pharmaceuticals/Roche/Chugai's Tarceva and AstraZeneca's Iressa. According to the report, Tarceva is the second-most commonly prescribed targeted therapy in the first line after Avastin.

While Avastin, Tarceva and Iressa have shown modest efficacy in select patient populations, other agents in late-stage development have struggled to reach the non-small-cell lung cancer drug market. Three targeted therapies -- Bristol-Myers Squibb/Eli Lilly/Merck KGaA's Erbitux, AstraZeneca's Zactima and Pfizer's figitumumab -- experienced recent setbacks in ongoing Phase III clinical trials or in receiving approval from the European Medicines Agency.

"The landscape for non-small-cell lung cancer will shift over the next several years as oncologists and payers grapple with the role of maintenance/consolidation therapy, increasing uptake of targeted therapies in the first-line setting and with the potential launch of new biologic ag
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Majority of Surveyed Pharmacy Directors Expect To Cover Pfizers Tanezumab If It Is Approved for the Treatment of Chronic Pain
2. Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roches Actemra for Rheumatoid Arthritis
3. Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections
4. Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line
5. Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
6. European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient
7. A Drugs Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections
8. Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8
9. Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
10. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
11. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013  B. Braun Medical Inc. (B.Braun) ... safety with products, services and education focused on ... innovative Outlook® 400ES and Space Infusion Systems, and ... the American Association of Critical-Care Nurses (AACN) National ... Boston Convention Center. ...
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- It is no secret that Americans have ... or obese gyms and supplement companies are in line to ... primarily related to dietary issues and a lack of physical ... a glandular problem or even a vitamin deficiency. ... is a lack of vitamin b12 . The vitamin ...
(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- Today at American ... Christine Ginocchio discussed Specific Technologies ... rapid identification of microorganisms producing bloodstream infection. Dr. ... of the Division of Infectious Disease Diagnostics at ... not-for-profit, non-sectarian health system. (Photo: ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... Lines for Therapeutic ... Cloning, ... to report, and painstakingly document, the cloning of a,human embryo using donated ... study was published online today by the journal "Stem,Cells.", (Logo: ...
... Cataract surgery involves,removing a clouded natural lens from ... While the operation itself hasn,t changed much over recent,years, ... newer lenses,is their ability to reduce the need for ... Medical School., The Aging Eye: Preventing and Treating ...
Cached Medicine Technology:Study Reports Successful Cloning of Human Embryo Using Adult DNA 2Study Reports Successful Cloning of Human Embryo Using Adult DNA 3New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery 2
(Date:5/20/2013)... Bradley, Illinois (PRWEB) May 20, 2013 ... assisted living community in Lake County, Illinois, is hosting ... 24. , The community, which is located at 3775 ... all incomes, including those on Medicaid, who need some ... our delicious breakfast buffet and games of bingo," says ...
(Date:5/20/2013)... (PRWEB) May 21, 2013 The ... product type into two categories - semi-automated and ... is classified into five categories, namely, hospitals, pre-hospital, ... is forecast till 2017. Automated external defibrillators play ... sudden cardiac arrest victims. Considering the life-saving potential ...
(Date:5/20/2013)... Minneapolis, MN (PRWEB) May 20, 2013 When ... right bed is only part of the process. Much of ... over the internet involves not knowing what to expect. ... expert advice consumers can use to ensure their purchase proves ... When You Buy a Mattress Online ”, readers find helpful ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Recent ... importance of using green and sustainable inputs in ... has implemented regulations to promote the use of ... Packaging and Labelling Services industry . “Tax subsidies ... trend,” says IBISWorld industry analyst Deonta Smith. “For ...
(Date:5/20/2013)... Fastcare Miami Beach clinic advises patients to treat ... as if not treated, it may involve the ureter and ... urinary tract infection in itself is not life threatening, if ... pyelonephritis. Women seem to have many more urinary tract infections ... as women after the age of fifty. , As ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Fastcare Advises on How to Prevent a UTI 2
... for Home Oxygen Therapy to Less Than Half of 1997 ... prepare to celebrate the New Year, the home oxygen community ... Medicare policy changes that will present many challenges to beneficiaries ... in the form of a 36-month cap on payments for ...
... WASHINGTON, Dec. 31 Each Sunday throughout January, ... that tells the compelling and inspirational stories of ... six-time Grammy Award winner Naomi Judd. Sharing Miracles ... across the United States. Judd, one-half of the ...
... Ltd. (NYSE Alternext,US: SVA), a leading provider of vaccines ... the Company,s inactivated hepatitis A vaccine,Healive(R), following a report ... District,in the City of Beijing on November 27, 2008. ... autopsy results, the death was caused by,myocarditis, an inflammation ...
... Calif., Dec. 31 Watson Pharmaceuticals, Inc. (NYSE: ... and specialty branded pharmaceuticals, today announced that its ... the United States Food and Drug Administration to ... mint flavor, in the 2 mg and 4 ...
... to Dock, a U.S. based Non-Governmental Organization (NGO), sent over $3,000,000 ... ... (Vocus) December 31, 2008 -- In a continent often ... attention paid to the many uplifting success stories. Among ...
... biopsy is still considered the gold standard for grading, ... it remains a primary source for acquiring new knowledge ... the fibrosis and inflammatory tissue detectable in liver biopsy ... the closest-to-real effects of new antiviral molecules on the ...
Cached Medicine News:Health News:Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities 2Health News:Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities 3Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 2Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 3Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 4Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 5Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 6Health News:Sinovac Announces that Government Investigation Rules Out Healive's Role in Child's Death 2Health News:Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum 2Health News:Good News in Africa: Beyond the headlines 2Health News:A rigorous method for liver biopsy 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: